LY3971297 Clinical Trials (2026): 2 Studies for Healthy & Heart Failure
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
2 LY3971297 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 2 indications (including Healthy & Heart Failure) and 315 total planned enrollment. 2 LY3971297 clinical trials are actively recruiting at 3 U.S. sites across 3 states. Most recent activity: NCT07547540 (Aug 2027).
Where to Participate: All LY3971297 Trial Sites in the U.S. (3 sites across 3 states)
Every actively recruiting LY3971297trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| CA | CenExel ACT | Anaheim92801 | NCT06148272 | Map |
| FL | Clinical Pharmacology of Miami | Miami33172 | NCT06148272 | Map |
| TX | ICON Early Phase Services | San Antonio78209 | NCT06148272 | Map |
LY3971297 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | not yet recruiting | Total |
|---|---|---|---|
| P1 | 1 | 1 | 2 |
Recruiting LY3971297 clinical trials (2)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07547540 | A Study of LY3971297 in Participants With Heart Failure | P1 | Heart Failure | 90 | Jun 2026 |
| NCT06148272 | A Study of LY3971297 in Healthy Participants | P1 | Healthy | 225 | Dec 2023 |
LY3971297 clinical trials by indication
Heart Failure (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07547540 | — | P1 | not yet recruiting | A Study of LY3971297 in Participants With Heart Failure |
Healthy (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT06148272 | — | P1 | recruiting | A Study of LY3971297 in Healthy Participants |
All LY3971297 trials (2)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07547540 | A Study of LY3971297 in Participants With Heart Failure | P1 | not yet recruiting | 90 | Eli Lilly and Company | Jun 2026 | |
| NCT06148272 | A Study of LY3971297 in Healthy Participants | P1 | recruiting | 225 | Eli Lilly and Company | Dec 2023 |
LY3971297 clinical trials: frequently asked questions
- How many LY3971297 clinical trials are there?
- 2 LY3971297 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are LY3971297 clinical trials recruiting in 2026?
- Yes — 1 LY3971297 trial is actively recruiting in 2026, with 3 U.S. sites across 3 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is LY3971297 being studied for?
- LY3971297 is being studied for Healthy, Heart Failure, Heart Failure, Diastolic, Heart Failure, Systolic, Hypertension and 1 more. The trials are grouped by indication on this page.
- What phase is LY3971297 in?
- LY3971297 clinical trials span 2 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors LY3971297 clinical trials?
- The lead sponsor across the most LY3971297 trials is Eli Lilly and Company. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming LY3971297as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: